GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telomir Pharmaceuticals Inc (NAS:TELO) » Definitions » Net Interest Income (for Banks)

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Net Interest Income (for Banks)


View and export this data going back to 2024. Start your Free Trial

What is Telomir Pharmaceuticals Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Telomir Pharmaceuticals (Telomir Pharmaceuticals) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.